N. Hynes

Oncology · 2003–2009

A researcher in the Science corpus: 6 papers; trusts 11 researchers and is trusted by 12 researchers here, as inferred from the citation graph.

Subfields

Whom N. Hynes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. H. Horlings
  2. Thomas Holbro
  3. Y. Yarden
  4. Hyun-soo Cho
  5. C. Hudis
  6. J. Engelman
  7. H. Lane
  8. M. Sliwkowski
  9. D. Hanahan
  10. William Pao

Who trusts N. Hynes overall

  1. D. Hanahan
  2. S. Bhattacharyya
  3. J. Baselga
  4. R. Weinberg
  5. M. Scaltriti
  6. M. Lacouture
  7. Rachel A. Kudgus
  8. William Pao
  9. M. Wieduwilt
  10. E. K. Kim

Papers from N. Hynes's perspective

Ordered by how strongly the researchers N. Hynes trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  2. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets (Nature Medicine)
  3. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
  4. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. (Cancer Cell)
  5. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
  6. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. (Molecules and Cells)
  7. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. (Cell)
  8. Epidermal growth factor receptor: mechanisms of activation and signalling. (Experimental Cell Research)
  9. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  10. Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)

Their papers